Scientists checked interferon on efficiency against Koronavirus
Show original
Source: information agency "RIA Novosti" At Koronavirus Rekombinantny interferon beta-1 is useless. Such conclusion was drawn by scientists from United States of America during clinical trial. Results The Lancet published Respiratory Medicine. Scientists from Institutes an allergy and infectious diseases at National institutes health care of United States of America during clinical tests beta 1a against kovida revealed Rekombinantny interferon beta-1. The essence of research was that as additional treatment to patients from Koronavirus...